142 related articles for article (PubMed ID: 35689790)
1. First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database.
Benevent J; Araujo M; Beau AB; Sicard D; Sommet A; Hurault-Delarue C; Lacroix I; Damase-Michel C
Infection; 2023 Feb; 51(1):137-146. PubMed ID: 35689790
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study.
Philipps W; Fietz AK; Meixner K; Bluhmki T; Meister R; Schaefer C; Padberg S
Infection; 2020 Feb; 48(1):57-64. PubMed ID: 31302868
[TBL] [Abstract][Full Text] [Related]
3. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
Goldberg O; Koren G; Landau D; Lunenfeld E; Matok I; Levy A
J Clin Pharmacol; 2013 Sep; 53(9):991-5. PubMed ID: 23873250
[TBL] [Abstract][Full Text] [Related]
4. Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.
Beau AB; Hurault-Delarue C; Vial T; Montastruc JL; Damase-Michel C; Lacroix I
BJOG; 2014 Jun; 121(7):895-900. PubMed ID: 24512604
[TBL] [Abstract][Full Text] [Related]
5. Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database.
Araujo M; Vabre C; Benevent J; Sommet A; Damase-Michel C; Hurault-Delarue C; Lacroix I
Drug Saf; 2021 Jul; 44(7):787-796. PubMed ID: 33970448
[TBL] [Abstract][Full Text] [Related]
6. Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database.
Araujo M; Hurault-Delarue C; Sommet A; Damase-Michel C; Lacroix I
Mycoses; 2022 Apr; 65(4):481-489. PubMed ID: 35067990
[TBL] [Abstract][Full Text] [Related]
7. First epidemiological data for venotonics in pregnancy from the EFEMERIS database.
Lacroix I; Beau AB; Hurault-Delarue C; Bouilhac C; Petiot D; Vayssière C; Vidal S; Montastruc JL; Damase-Michel C
Phlebology; 2016 Jun; 31(5):344-8. PubMed ID: 26060062
[TBL] [Abstract][Full Text] [Related]
8. [Drug in pregnancy: studies in the French database EFEMERIS].
Damase-Michel C; Lacroix I; Hurault-Delarue C; Beau AB; Montastruc JL;
Therapie; 2014; 69(1):91-100. PubMed ID: 24698193
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
Huttner A; Kowalczyk A; Turjeman A; Babich T; Brossier C; Eliakim-Raz N; Kosiek K; Martinez de Tejada B; Roux X; Shiber S; Theuretzbacher U; von Dach E; Yahav D; Leibovici L; Godycki-Cwirko M; Mouton JW; Harbarth S
JAMA; 2018 May; 319(17):1781-1789. PubMed ID: 29710295
[TBL] [Abstract][Full Text] [Related]
10. Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss - An observational study using the EFEMERIS database.
Vabre C; Araujo M; Damase-Michel C; Hurault-Delarue C; Lacroix I
Therapie; 2022; 77(4):405-412. PubMed ID: 34756562
[TBL] [Abstract][Full Text] [Related]
11. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
Keating GM
Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
[TBL] [Abstract][Full Text] [Related]
12. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women.
Van Pienbroek E; Hermans J; Kaptein AA; Mulder JD
Pharm World Sci; 1993 Dec; 15(6):257-62. PubMed ID: 8298585
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women - A systematic review and meta-analysis.
Konwar M; Gogtay NJ; Ravi R; Thatte UM; Bose D
J Chemother; 2022 May; 34(3):139-148. PubMed ID: 34151754
[TBL] [Abstract][Full Text] [Related]
14. [First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy].
Lacroix I; Hurault-Delarue C; Kessler S; Guitard C; Vidal S; Albouy-Cossard C; Montastruc JL; Damase-Michel C
Gynecol Obstet Fertil; 2011 Dec; 39(12):694-7. PubMed ID: 21855385
[TBL] [Abstract][Full Text] [Related]
15. Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis.
Goldberg O; Moretti M; Levy A; Koren G
J Obstet Gynaecol Can; 2015 Feb; 37(2):150-156. PubMed ID: 25767948
[TBL] [Abstract][Full Text] [Related]
16. Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results.
Thoumsin H; Aghayan M; Lambotte R
Infection; 1990; 18 Suppl 2():S94-7. PubMed ID: 2286469
[TBL] [Abstract][Full Text] [Related]
17. Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin.
Mannucci C; Dante G; Miroddi M; Facchinetti F; D'Anna R; Santamaria A; Lenti MC; Vannacci A; Calapai F; Perone M; Migliardi G; Alibrandi A; Navarra M; Calapai G
J Matern Fetal Neonatal Med; 2019 Jan; 32(1):125-128. PubMed ID: 28868940
[TBL] [Abstract][Full Text] [Related]
18. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin: an old--new antibiotic.
Raz R
Clin Microbiol Infect; 2012 Jan; 18(1):4-7. PubMed ID: 21914036
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections - United States, 2014.
Ailes EC; Summers AD; Tran EL; Gilboa SM; Arnold KE; Meaney-Delman D; Reefhuis J
MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(1):18-22. PubMed ID: 29324733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
